Candida.

Persistent cases of cap leaven or presumptive ductal fungus are frequently treated with oral fluconazole (Diflucan). However, without clinical trials that writing the efficacy and condom of fluconazole for mammary leavening, it is especially important to have a very high dubiety prior to direction. Fluconazole is not approved by the Food and Drug Governance for mammary candidosis. The doses that are used, a 200- to 400-mg handling dose and then 100 to 200 mg once a day for 14 to 21 days, are doses that have been used to sustenance candidiasis infections in other organs (e.g., the vesica, esophagus, and liver) in immunocompromised persons. In randomized controlled studies, the side effects from fluconazole at the aforementioned doses were minimal. Fluconazole is often prescribed to continue for 1 to 2 weeks after symptoms have resolved to ensure cure and prevent reoccurrence.